Search Results
NMS-873 2 mg | 99.71%
TargetMol
NSI189 2 mg | 99.45%
TargetMol

NSI-189 is a nootropic and neurogenic research chemical derived from nicotinamide and pyrazine.
More Information Supplier PageTenovin-6 1 mg | 100.00%
TargetMol
MDL-29951 2 mg | 99.07%
TargetMol
GNE-7915 5 mg | Purity Not Available
TargetMol

GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageGNE-7915 25 mg | Purity Not Available
TargetMol

GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageISX-9 25 mg | 98.26%
TargetMol

ISX9 is necessary to activate neuron-specific genes as neurogenesis inducer.
More Information Supplier PageISX-9 2 mg | 98.26%
TargetMol

ISX9 is necessary to activate neuron-specific genes as neurogenesis inducer.
More Information Supplier PageJ-147 100 mg | 99.61%
TargetMol

J-147 is an experimental drug with reported effects against both Alzheimer’s disease and ageing in mouse models of accelerated aging. It is a curcumin derivative and a potent neurogenic and neuroprotective drug candidate initially developed for the treatment of neurodegenerative conditions associated with aging that impacts many pathways implicated in the pathogenesis of diabetic neuropathy.
More Information Supplier Page